Friday, April 05, 2024 11:34:53 PM
April 5, 2024
CDIX
Cardiff Lexington, which is holding company focused on acquiring business primarily in the healthcare sector, announced terms for its IPO on Friday. The company is currently listed on the OTC under the symbol "CDIX." It originally filed in July 2023 but was ineligible for tracking.
The Las Vegas, NV-based company plans to raise $8 million by offering 1.6 million shares at a price range of $4 to $6. At the midpoint of the proposed range, Cardiff Lexington would command a market value of $204 million.
Cardiff Lexington is a holding company focused on acquiring what it believes are undervalued and undercapitalized companies, primarily in the healthcare industry. The company intends to build a portfolio that consists of approximately 80% established profitable niche small to mid-sized healthcare companies, and 20% second stage startups in healthcare. In May 2021, Cardiff acquired Nova Ortho and Spine, which operates a group of regional primary specialty and ancillary care facilities throughout Florida that provide traumatic injury victims with primary care evaluations, interventional pain management, and specialty consultation services. The company also owns a real estate company, Edge View Properties.
Cardiff Lexington was founded in 1986 and booked $12 million in revenue for the 12 months ended December 31, 2023. It plans to list on the NYSE American under the symbol CDIX. Craft Capital Management and R.F. Lafferty & Co. are the joint bookrunners on the deal.
Recent CDIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 01/04/2024 01:50:17 PM
- Form DEFR14C - Revised information statement materials, definitive • Edgar (US Regulatory) • 11/29/2023 03:18:50 PM
- Form SC 13G - Statement of acquisition of beneficial ownership by individuals • Edgar (US Regulatory) • 11/16/2023 09:11:50 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 11/16/2023 07:06:22 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/14/2023 05:29:20 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 10/25/2023 07:05:06 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/05/2023 07:56:42 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 08/14/2023 05:25:09 PM
- Form S-1/A - General form for registration of securities under the Securities Act of 1933: [Amend] • Edgar (US Regulatory) • 08/03/2023 08:51:51 PM
- Form S-1 - General form for registration of securities under the Securities Act of 1933 • Edgar (US Regulatory) • 07/19/2023 09:02:17 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 06/29/2023 08:04:36 PM
FEATURED Cannabix Technologies to Deliver Breath Logix Alcohol Screening Device to Australia • Apr 30, 2024 8:53 AM
Hydromer, Inc. Reports Preliminary Unaudited Financial Results for First Quarter 2024 • HYDI • Apr 29, 2024 9:10 AM
Avant Technologies to Implement AI-Empowered, Zero Trust Architecture in Its Data Centers • AVAI • Apr 29, 2024 8:00 AM
Bantec Reports an Over 50 Percent Increase in Sales and Profits in Q1 2024 from Q1 2023 • BANT • Apr 25, 2024 10:00 AM
Cannabix's Breath Logix Alcohol Device Delivers Positive Impact to Private Monitoring Agency in Montana, USA • BLO • Apr 25, 2024 8:52 AM
Kona Gold Beverages, Inc. Announces Name Change to NuVibe, Inc. and Initiation of Ticker Symbol Application Process • KGKG • Apr 25, 2024 8:30 AM